Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 11, 2025

Mutation-specific structural changes in BRAF: understanding dimerization and drug binding for targeted therapy.

View Full Paper
Ask AI
Bookmark
Share

Authors

MZMinjie ZhaoRZRabia ZafarSSSaad Serfraz

Discussion

Loading...

Member takes

Overview

Molecular dynamics reveal how BRAF mutations affect drug binding and dimerization, indicating new precision oncology strategies.

Key Points

  • BRAF dimerization with CRAF is crucial for MAPK/ERK signaling and its disruption leads to cancer development.
  • Mutations like V600E create a resistant form bypassing dimerization, affecting drug binding and response.
  • Five BRAF mutations were examined through simulations and drug interaction studies to understand structural changes.
  • Findings support the need for mutation-guided approaches in precision oncology to improve therapeutic outcomes.

Cite This Study

Zhao et al. (2025) studied this question.

synapsesocial.com/papers/689e03d9d61984b91e13cbb9https://doi.org/10.1080/07391102.2025.2543358
View Full Paper
Ask AI
Bookmark
Share